Latest news articles

Added 9 months ago Drug news

Urovant Sciences licenses vibegron from Merck Inc. and will initiate a Phase III trial in 2017 for overactive bladder treatment.

Roivant Sciences, announced the formation of Urovant Sciences, a new company focused on developing innovative therapies for urologic conditions. Urovant's...

Added 2 years ago Drug news

Phase III extension studies show advantages of Botox (onabotulinumtoxinA) in urinary incontinence- Allergan

Allergan has announced that results from an extension study of two phase III trials showed that long-term Botox (onabotulinumtoxinA) treatment...

Added 3 years ago Drug news

IQWiG finds no added benefit for Myrbetriq in Overactive Bladder-Astellas

In an early benefit assessment, the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether Myrbetriq/Betmiga (mirabegron),...

Search all news articles for Other diseases of bladder and urethra

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.



See information on best practice in solid organ transplantation, and expert discussions on related hot topics.

Fabry Disease

Fabry Disease

Explore the pathophysiology and treatment options for Fabry disease, a deficiency of the lysosomal enzyme alpha-galactosidase A

Load more


Guidelines on the Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS)

Recommendations apply to men aged 40 years or older who seek professional help for various non-neurogenic benign forms of LUTS...

Added 2 years ago

Search all guidelines for Other diseases of bladder and urethra

Journal articles

Association between coronary artery disease severity and overactive bladder in geriatric patients.

Purpose: To investigate the association between overactive bladder (OAB) and coronary artery disease (CAD) as demonstrated on coronary angiography in patients > 65 years.

Added 2 months ago

Comparative assessment of the efficacy of onabotulinumtoxinA and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta-analysis.

Objectives: To compare the efficacy of onabotulinumtoxinA, mirabegron, and anticholinergics in adults with idiopathic overactive bladder (OAB) using network meta-analysis (NMA).

Added 2 months ago

Enuresis and overactive bladder in children: what is the relationship between these two conditions?

Evaluate clinical aspects associated with the presence of nocturnal enuresis (NE) in children with a diagnosis of overactive bladder (OAB).

Added 1 year ago

Search all journal articles for Other diseases of bladder and urethra


Daytime wetting in children

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
Registration required
Subscription fee
Search all CME for Other diseases of bladder and urethra